Three Parent Babies: Unethical, Unnecessary, Unsafe
By Philippa Taylor,
BioNews
| 02. 16. 2015
Untitled Document
In a recent debate organised by the Progress Educational Trust in Parliament - 'Mitochondrial Donation: Is It Safe? Is It Ethical?' - I spoke about the ethical issues raised by techniques to avoid the passing on of inherited mitochondrial disorders, pro-nuclear transfer (PNT) and maternal spindle transfer (MST). It is claimed that because these new techniques will prevent terrible disease, save lives and are safe enough to use on humans, it would be unethical not to use them. The techniques, it is argued, are as acceptable as any transplant, or similar to replacing batteries in a camera.
Read more...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...